Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Other Non-Current Liabilities of $30000.0 for Q1 2026, up 1400.0% on a YoY basis from $2000.0 in Q1 2025, and up 3.45% sequentially from $29000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Other Non-Current Liabilities data on file, last reported at $30000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 1400.0% year-over-year to $30000.0; the trailing twelve-month figure through Mar 2026 stood at $30000.0 (up 1400.0% YoY), and the FY2025 full-year result was $29000.0, down 59.72% from the prior year.
- Other Non-Current Liabilities grew to $30000.0 in Q1 2026, from $29000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $16.7 million in Q3 2025 to a low of $2000.0 in Q4 2023.
- A 4-year average of $2.1 million and a median of $15500.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Peak annual rise in Other Non-Current Liabilities reached 836500.0% in 2025, while the deepest fall reached 59.72% in 2025.
- Tracing CAMP's Other Non-Current Liabilities over 4 years: stood at $2000.0 in 2023, then soared by 3500.0% to $72000.0 in 2024, then tumbled by 59.72% to $29000.0 in 2025, then gained by 3.45% to $30000.0 in 2026.
- Business Quant data shows CAMP's Other Non-Current Liabilities at $30000.0 in Q1 2026, $29000.0 in Q4 2025, and $16.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 16.73 Mn |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |